Nivolumab for patients with recurrent glioblastoma progressing on bevacizumab: a retrospective case series

Overview of attention for article published in Journal of Neuro-Oncology, May 2017

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#33 of 2,985)
High Attention Score compared to outputs of the same age (92nd percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news: 4 news outlets

twitter: 1 X user

Citations

dimensions_citation: 46 Dimensions

Readers on

mendeley: 88 Mendeley

Summary News X Dimensions citations

So far, Dimensions has found 46 publications that cite this research output.

46

The most recent citing publications are shown below. View all 46 publications that cite this research output on Dimensions.

From glioma gloom to immune bloom: unveiling novel immunotherapeutic paradigms-a review

Article in Journal of Experimental & Clinical Cancer Research (February 2024)

SOMATIC DEFICIENT MISMATCH REPAIR ASSESSED BY IMMUNOHISTOCHEMISTRY AND CLINICAL FEATURES IN BRAZILIAN GLIOBLASTOMA PATIENTS

Article in Experimental Oncology (December 2023)

Kunitz-type protease inhibitor TFPI2 remodels stemness and immunosuppressive tumor microenvironment in glioblastoma

Article in Nature Immunology (September 2023)